Literature DB >> 28212149

New developments for the detection and treatment of cardiac vasculopathy.

Kevin J Clerkin1, Ziad A Ali, Donna M Mancini.   

Abstract

PURPOSE OF REVIEW: Cardiac allograft vasculopathy (CAV) is a major limitation to long-term survival after heart transplantation. Innovative new techniques to diagnose CAV have been applied to detect disease. This review will examine the current diagnostic and treatment options available to clinicians for CAV. RECENT
FINDINGS: Diagnostic modalities addressing the pathophysiology underlying CAV (arterial wall thickening and decreased coronary blood flow) improve diagnostic sensitivity when compared to traditional (angiography and dobutamine stress echocardiography) techniques.
SUMMARY: Limited options are available to prevent and treat CAV; however, progress has been made in making an earlier and more accurate diagnosis. Future research is needed to identify the optimal time to modify immunosuppression and investigate novel treatments for CAV.

Entities:  

Year:  2017        PMID： 28212149      PMCID： PMC5654693          DOI： 10.1097/HCO.0000000000000388

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN： 0268-4705            Impact factor:   2.161


  98 in total

Review 1.  Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

Authors:  D O Taylor; R L Yowell; A G Kfoury; E H Hammond; D G Renlund
Journal:  J Heart Lung Transplant       Date:  2000-06       Impact factor: 10.247

2.  Cardiac magnetic resonance perfusion imaging identifies transplant arteriopathy by a reduced endomyocardial resting perfusion.

Authors:  Olaf M Muehling; Prasad Panse; Michael Jerosch-Herold; Betsy V Wilson; Robert F Wilson; Norbert M Wilke; Leslie W Miller
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

3.  Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.

Authors:  Shikhar Agarwal; Akhil Parashar; Samir R Kapadia; E Murat Tuzcu; Dhruv Modi; Randall C Starling; Guilherme H Oliveira
Journal:  JACC Heart Fail       Date:  2014-06       Impact factor: 12.035

4.  Revascularization procedures in patients with transplant coronary artery disease.

Authors:  V S Patel; B Radovancevic; W Springer; O H Frazier; E Massin; J Benrey; K Kadipasaoglu; D A Cooley
Journal:  Eur J Cardiothorac Surg       Date:  1997-05       Impact factor: 4.191

5.  Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography.

Authors:  Shinichi Nunoda; Haruhiko Machida; Akihiko Sekikawa; Kazunobu Shitakura; Kiyotaka Okajima; Yutaka Kubo; Eiko Ueno; Kuniaki Otsuka
Journal:  Circ J       Date:  2010-03-10       Impact factor: 2.993

6.  Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death.

Authors:  S M Hollenberg; L W Klein; J E Parrillo; M Scherer; D Burns; P Tamburro; M Oberoi; M R Johnson; M R Costanzo
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

7.  Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.

Authors:  E Murat Tuzcu; Samir R Kapadia; Ravish Sachar; Khaled M Ziada; Timothy D Crowe; Jingyuan Feng; William A Magyar; Robert E Hobbs; Randall C Starling; James B Young; Patrick McCarthy; Steven E Nissen
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

8.  Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients.

Authors:  A Samman; C Imai; L Straatman; J Frolich; K Humphries; A Ignaszewski
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

9.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.

Authors:  Bernhard A Herzog; Lars Husmann; Ines Valenta; Oliver Gaemperli; Patrick T Siegrist; Fabian M Tay; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

10.  Characterization of human atherosclerosis by optical coherence tomography.

Authors:  Hiroshi Yabushita; Brett E Bouma; Stuart L Houser; H Thomas Aretz; Ik-Kyung Jang; Kelly H Schlendorf; Christopher R Kauffman; Milen Shishkov; Dong-Heon Kang; Elkan F Halpern; Guillermo J Tearney
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690
View more
  8 in total

1.  Semi-quantitative myocardial perfusion MRI in heart transplant recipients at rest: repeatability in healthy controls and assessment of cardiac allograft vasculopathy.

Authors:  Travis B DeSa; Muhannad A Abbasi; Julie A Blaisdell; Kai Lin; Jeremy D Collins; James C Carr; Michael Markl
Journal:  Clin Imaging       Date:  2019-12-19       Impact factor: 1.605

Review 2.  The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences.

Authors:  C Sciaccaluga; N Ghionzoli; G E Mandoli; N Sisti; F D'Ascenzi; M Focardi; S Bernazzali; G Vergaro; M Emdin; S Valente; M Cameli
Journal:  Heart Fail Rev       Date:  2021-08-12       Impact factor: 4.654

3.  Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.

Authors:  Ludwig T Weckbach; Ulrich Maurer; Rene Schramm; Bruno C Huber; Korbinian Lackermair; Max Weiss; Bruno Meiser; Christian Hagl; Steffen Massberg; Sandra Eifert; Ulrich Grabmaier
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

4.  Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac 82Rb PET.

Authors:  Uttam M Shrestha; Maria Sciammarella; Miguel Hernandez Pampaloni; Elias H Botvinick; Grant T Gullberg; Teresa DeMarco; Youngho Seo
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-29       Impact factor: 2.357

5.  TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy.

Authors:  Allison C Ostriker; Yi Xie; Raja Chakraborty; Ashley J Sizer; Yalai Bai; Min Ding; Wen-Liang Song; Anita Huttner; John Hwa; Kathleen A Martin
Journal:  Circulation       Date:  2021-06-11       Impact factor: 39.918

6.  Diabetic vasculopathy: macro and microvascular injury.

Authors:  Roberto I Mota; Samuel E Morgan; Edward M Bahnson
Journal:  Curr Pathobiol Rep       Date:  2020-01-27

7.  Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography.

Authors:  Christian Zanchin; Kyohei Yamaji; Carolin Rogge; Dorothea Lesche; Thomas Zanchin; Yasushi Ueki; Stephan Windecker; Paul Mohacsi; Lorenz Räber; Vilborg Sigurdardottir
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

8.  Coronary revascularization after heart transplant - the search for prognostic factors.

Authors:  Bartlomiej Guzik; Elżbieta Szczepanek; Łukasz Niewiara; Marcin Nosal; Karol Wierzbicki; Marcin Krzanowski; Piotr Szolc; Bogusław Kapelak; Krzysztof F Żmudka
Journal:  Arch Med Sci       Date:  2020-04-18       Impact factor: 3.318
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.